TH-263
TH-263, a diaryl sulfonamide derivative, is inactive toward both LIMK1 and LIMK2 and thus can be used as negative control for TH-257[1].
Product Specifications
CAS Number
313520-94-4
UNSPSC
12352005
Hazard Statement
H302, H315, H319
Target
LIM Kinase (LIMK)
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/th-263.html
Purity
99.0
Solubility
DMSO : ≥ 50 mg/mL
Smiles
O=C(NCC1=CC=CC=C1)C2=CC=C(S(=O)(NCC3=CC=CC=C3)=O)C=C2
Molecular Formula
C21H20N2O3S
Molecular Weight
380.46
Precautions
H302, H315, H319
References & Citations
[1]Manetti F. Recent advances in the rational design and development of LIM kinase inhibitors are not enough to enter clinical trials. Eur J Med Chem. 2018 Jul 15;155:445-458.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
L4502-21H 100 µL
LRRK2 (Leucine-rich Repeat Kinase 2, RIP7, PARK8, Dardarin)
Sign In for Pricing
View Details